Prostate Cancer Press Releases by globenewswire

News Search | All News Topics > Prostate Cancer News Topics: By Country | By State ; Press Releases by Industry Channel
Submit Your Press Release
Distribution channels: Healthcare & Pharmaceuticals Industry
Mar 10, 2025
Orion to open new Biologics R&D Centre in Cambridge, UK in 2025 to support global growth strategy, considers ...
Mar 10, 2025
Orion avaa uuden biologisten lääkkeiden T&K-keskuksen Cambridgeen vuonna 2025 tukemaan globaalia kasvustrategiaa – yhtiö ...
Mar 10, 2025
AAVantgarde announces 2 presentations at ARVO 2025 annual meeting: LUCE-1 clinical trial data from Usher 1B program & ...
Mar 9, 2025
ACTG Presents Study at CROI Demonstrating Increased Risk of Obesity and Cardiometabolic Disease After Switch to ...
Mar 8, 2025
Curia kündigt strategische Refinanzierung zur Unterstützung weiteren Wachstums an
Mar 8, 2025
Curia anuncia refinanciación estratégica para apoyar su crecimiento continuo
Mar 8, 2025
Curia annonce un refinancement stratégique visant à soutenir la poursuite de sa croissance
Mar 8, 2025
Curia הכריזה על אסטרטגיית מימון מחדש לתמיכה בהמשך הצמיחה
Mar 8, 2025
Curia Umumkan Pembiayaan Ulang (Refinancing) Strategis untuk Mendukung Pertumbuhan yang Berkelanjutan
Mar 8, 2025
キュリア (Curia)、継続的な成長を支える戦略的リファイナンスを発表
Mar 8, 2025
Curia, 지속적 성장 지원하기 위한 전략적 리파이낸싱 발표
Mar 8, 2025
Curia Mengumumkan Pembiayaan Semula Strategik untuk Menyokong Pertumbuhan Berterusan
Mar 8, 2025
Curia Anuncia Refinanciamento Estratégico em Apoio ao Crescimento Contínuo
Mar 8, 2025
Curia ประกาศกลยุทธ์รีไฟแนนซ์เพื่อสนับสนุนการเติบโตอย่างต่อเนื่อง
Mar 8, 2025
Curia 宣布战略性再融资，助力持续增长
Mar 8, 2025
Curia 公佈策略性再融資，為持續增長提供支持
Mar 8, 2025
Press Release: Dupixent late-breaking positive pivotal data in bullous pemphigoid presented at AAD
Mar 8, 2025
Communiqué de presse : Présentation de dernière heure de données pivots positives sur le Dupixent dans le traitement de ...
Mar 8, 2025
Dupixent® (dupilumab) Late-Breaking Positive Pivotal Data in Bullous Pemphigoid Presented at AAD
Mar 8, 2025
Late-Breaking ESK-001 Phase 2 OLE Data Presented at 2025 AAD Annual Meeting Demonstrate Robust Clinical Responses Over ...
Mar 7, 2025
ARCPOINT ANNOUNCES CLOSING OF NON-BROKERED PRIVATE PLACEMENT AND ANNOUNCES UPSIZE
Mar 7, 2025
Kestra Medical Technologies, Ltd. Announces Closing of Upsized Initial Public Offering
Mar 7, 2025
Better Choice Company to Host Fourth Quarter and Full Year 2024 Financial Results Conference Call on March 27th at 4:30 ...
Mar 7, 2025
Drs. Jeffrey Lieberman, M.D. and David Sinclair, Ph.D. to Present ‘The New Frontier of Longevity Science: Living Well ...
Mar 7, 2025
Curia Announces Strategic Refinancing to Support Continued Growth
Mar 7, 2025
Blueberries Medical Announces C$1 Million Non-Brokered Private Placement
Mar 7, 2025
Pennant Group to Participate in the 2025 Oppenheimer Annual Healthcare Conference
Mar 7, 2025
Cellectis to Report Fourth Quarter and Full Year 2024 Financial Results on March 13, 2025
Mar 7, 2025
Nature’s Fynd Wins Prestigious NEXTY Award for Dairy-Free Fy™ Yogurt
Mar 7, 2025
Codexis Announces New Employment Inducement Grants
Mar 7, 2025
Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Mar 7, 2025
Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Mar 7, 2025
Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Mar 7, 2025
SS Innovations International Launches the 2nd Global Robotic Surgery Conference, SMRSC 2025
Mar 7, 2025
Progyny, Inc. to Participate in Upcoming Investor Conferences
Mar 7, 2025
Advanced Biomed Inc. Announces Closing Of US$6.56 Million Initial Public Offering
Mar 7, 2025
Artax Biopharma Presents New Preclinical Data on Nck Modulators at 2025 AAD Annual Meeting
Mar 7, 2025
BioNexus Gene Lab Corp and ML Tech Partner to Enhance Ethereum-focused Treasury Strategy
Mar 7, 2025
Avacta Announces Promising Early Efficacy and Safety Data for AVA6000 in the Phase 1a Dose Escalation and Ongoing ...
Mar 7, 2025
Capricor Therapeutics to Present at Leerink’s Global Healthcare Conference 2025
Powered by EIN News